SOLACI Research Continues to Consolidate its Investigation Registries | REDCAP SOLACI

The Latin American Society of Interventional Cardiology has decided to hire the REDCap database platform to keep developing their research registries. 

In this regard, SOLACI’s Research Department continues to advance its mission of building clinical research lines to gather reliable information, which will allow us to define better therapeutic behaviors to adress the treatment of the different cardiovascular diseases in Latin America. 

At present, SOLACI Research is actively working on 3 registries. 

LATAM Bif Registry, carried out together with the Latin American Bifurcations Club, to assess the reality of coronary bifurcation treatment in Latin America,
SOLACI Peripheral Registry.
LATAM TAVI Registry.

Should you want to take part in any of SOLACI’s Registries, or should you wish to participate as a collaborator of the research departments, please write to research@solaci.org.

Let’s continue to strengthen the development of interventional cardiology in the region!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...